Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 1
2007 1
2008 1
2012 1
2013 1
2014 1
2015 1
2016 2
2017 2
2018 2
2019 3
2020 1
2021 3
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Ablation for Benign Liver Tumors: Current Concepts and Limitations.
Maruyama H, Tobari M, Nagamatsu H, Yamaguchi T, Shiina S. Maruyama H, et al. Among authors: nagamatsu h. J Clin Transl Hepatol. 2023 Feb 28;11(1):244-252. doi: 10.14218/JCTH.2022.00205. Epub 2022 Sep 6. J Clin Transl Hepatol. 2023. PMID: 36406314 Free PMC article. Review.
The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver Function.
Iwamoto H, Niizeki T, Nagamatsu H, Ueshima K, Tani J, Kuzuya T, Kasai K, Kooka Y, Hiraoka A, Sugimoto R, Yonezawa T, Tanaka S, Deguchi A, Shimose S, Shirono T, Sakai M, Suzuki H, Moriyama E, Koga H, Torimura T, Kawaguchi T, New Fp Study Group, Kurume Liver Cancer Study Group Of Japan. Iwamoto H, et al. Among authors: nagamatsu h. Cancers (Basel). 2022 Oct 5;14(19):4873. doi: 10.3390/cancers14194873. Cancers (Basel). 2022. PMID: 36230795 Free PMC article.
Immune-mediated Drug-induced Liver Injury Caused by Laninamivir Octanoate Hydrate.
Kawaguchi T, Arinaga-Hino T, Shimizu M, Tanikawa K, Tokushige T, Hirai S, Nagamatsu H, Tateishi H, Takata A, Ide T, Torimura T. Kawaguchi T, et al. Among authors: nagamatsu h. Intern Med. 2019 Sep 1;58(17):2501-2505. doi: 10.2169/internalmedicine.2740-19. Epub 2019 May 22. Intern Med. 2019. PMID: 31118398 Free PMC article.
Usefulness of a novel transarterial chemoinfusion plus external-beam radiation therapy for advanced hepatocellular carcinoma with tumor thrombi in the inferior vena cava and right atrium: Case study.
Shirono T, Koga H, Niizeki T, Nagamatsu H, Iwamoto H, Shimose S, Nakano M, Okamura S, Noda Y, Kamachi N, Kuromatsu R, Ogo E, Torimura T. Shirono T, et al. Among authors: nagamatsu h. Cancer Rep (Hoboken). 2022 Aug;5(8):e1539. doi: 10.1002/cnr2.1539. Epub 2021 Aug 24. Cancer Rep (Hoboken). 2022. PMID: 34431232 Free PMC article.
Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial.
Ikeda M, Kudo M, Aikata H, Nagamatsu H, Ishii H, Yokosuka O, Torimura T, Morimoto M, Ikeda K, Kumada H, Sato T, Kawai I, Yamashita T, Horio H, Okusaka T; Miriplatin TACE Study Group. Ikeda M, et al. Among authors: nagamatsu h. J Gastroenterol. 2018 Feb;53(2):281-290. doi: 10.1007/s00535-017-1374-6. Epub 2017 Aug 1. J Gastroenterol. 2018. PMID: 28766016 Free PMC article. Clinical Trial.
23 results